Members of the US Food and Drug Administration (FDA) Neurological Devices Panel reviewed safety issues and the risks and benefits of using the CoAxia NeuroFlo catheter in patients with ischemic stroke ...
MINNEAPOLIS, Minnesota –The medical device company CoAxia said it’s raised $21.5 million to complete clinical trials on its acute ischemic stroke treatment, submit results to the U.S. Food & Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback